Rejected at 2:11 a.m. May, 30, 2025 ] by Cameron
Author: mayomo28
Related Note: 1515267100492
Rationale for change

https://www.omim.org/entry/617347

This is the article AMBOSS cites for Type III. They assert type III "is characterized by hyperlipidemia due to accumulation of remnants of the triglyceride (TG)-rich lipoproteins (TGRL), very low density lipoproteins (VLDL), and chylomicrons (CM)." I believe that these changes ensure better clarity around what the research is saying about type III (an accumulation of chylomicrons/VLDL and their remnants) without committing specifically to exclusive elevations in VLDL and chylomicrons. This also helps align the information between AMBOSS, the table provided in the extra section, and information provided by pixorize (IDL is a VLDL remnant, therefore VLDL remnants being elevated is an easier logical jump to understand and make)
Source: AMBOSS - https://next.amboss.com/us/article/4o03XS?q=familial%20dysbetalipoproteinemia#Zcf3f04936e0fb0160f55c4cf97f37d23

Rejection reason

Amboss table still says that it's chylomicrons and VLDL that are elevated

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Empty field
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step2_v12::#B&B::02_Cardio::06_Other::03_Hyperlipidemia::Extra #AK_Step1_v12::#UWorld::Step::2064 #AK_Step1_v12::#UWorld::COMLEX::25173 #AK_Step1_v12::#Bootcamp::Biochemistry::09_Lipid_Metabolism::10_Familial_Dyslipidemias #AK_Step1_v12::#Pixorize::01_Biochemistry::04_Lipids::07_Familial_Dysbetalipoproteinemia #AK_Step1_v12::#OME::PreClinical::Biochemistry #AK_Step1_v12::#FirstAid::01_Biochem::06_Metabolism::48_Familial_dyslipidemias::*Type_3_Dysbetalipoproteinemia #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Biochemistry::Metabolism #AK_Step1_v12::^Systems::Biochem::BGadds #AK_Step1_v12::^Other::^EXPN::BGadd #AK_Step1_v12::#AMBOSS::GWaB5j #AK_Other::!AK_UpdateTags::AnKing_Image::MS::Inherited_Hyperlipoproteinemias #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Cardiology::Inherited_Hyperlipoproteinemia #AK_Step1_v12::#B&B::04_Biochem::05_Lipids::02_Hyperlipidemia::Extra #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::^Other::^FA_Updates::FA2018